EBM Technologies (ROCO:8409) Cyclically Adjusted Revenue per Share: NT$9.72 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8409 EBM Technologies Inc ROCO:8409
59 GF Score
Price NT$18.15
GF Value NT$29.54
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is EBM Technologies Cyclically Adjusted Revenue per Share?

EBM Technologies ROCO:8409 59 Cyclically Adjusted Revenue per Share is NT$9.72 as of Mar. 2026. GuruFocus rates ROCO:8409 with a GF Score™ of 59/100 and a GF Value™ of NT$29.54 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

EBM Technologies's adjusted revenue per share for the three months ended in Mar. 2026 was NT$1.685. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$9.72 for the trailing ten years ended in Mar. 2026.

During the past 12 months, EBM Technologies's average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of EBM Technologies was 1.60% per year. The lowest was -2.20% per year. And the median was 0.80% per year.

As of today (2026-07-30), EBM Technologies's current stock price is NT$18.15. EBM Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$9.72. EBM Technologies's Cyclically Adjusted PS Ratio of today is 1.87.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of EBM Technologies was 3.06. The lowest was 1.62. And the median was 2.19.


EBM Technologies  (ROCO:8409) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

EBM Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=18.15/9.72
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of EBM Technologies was 3.06. The lowest was 1.62. And the median was 2.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


EBM Technologies Cyclically Adjusted Revenue per Share Related Terms


EBM Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for EBM Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EBM Technologies Cyclically Adjusted Revenue per Share Chart

EBM Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.64 10.18 9.78 9.88 9.52

EBM Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.94 9.80 9.89 9.52 9.72

ROCO:8409 vs VEEV, BTSG, HQY: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, EBM Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EBM Technologies Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EBM Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where EBM Technologies's Cyclically Adjusted PS Ratio falls into.


ROCO:8409
59GF Score
EBM Technologies Inc ROCO:8409
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EBM Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EBM Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.685/330.2130*330.2130
=1.685

Current CPI (Mar. 2026) = 330.2130.

EBM Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.942 241.018 2.661
201609 2.135 241.428 2.920
201612 3.819 241.432 5.223
201703 1.741 243.801 2.358
201706 1.412 244.955 1.903
201709 1.553 246.819 2.078
201712 2.343 246.524 3.138
201803 1.328 249.554 1.757
201806 1.437 251.989 1.883
201809 1.240 252.439 1.622
201812 3.373 251.233 4.433
201903 1.637 254.202 2.126
201906 1.638 256.143 2.112
201909 1.118 256.759 1.438
201912 3.840 256.974 4.934
202003 2.292 258.115 2.932
202006 1.064 257.797 1.363
202009 1.526 260.280 1.936
202012 2.544 260.474 3.225
202103 0.974 264.877 1.214
202106 1.204 271.696 1.463
202109 1.522 274.310 1.832
202112 2.691 278.802 3.187
202203 6.627 287.504 7.611
202206 1.066 296.311 1.188
202209 1.234 296.808 1.373
202212 3.057 296.797 3.401
202303 0.979 301.836 1.071
202306 1.052 305.109 1.139
202309 1.362 307.789 1.461
202312 3.042 306.746 3.275
202403 0.841 312.332 0.889
202406 0.867 314.175 0.911
202409 1.516 315.301 1.588
202412 5.564 315.605 5.822
202503 0.727 319.799 0.751
202506 1.040 322.561 1.065
202509 3.533 324.800 3.592
202512 2.585 324.054 2.634
202603 1.685 330.213 1.685

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$9.72 mean?
EBM Technologies (ROCO:8409) has a Cyclically Adjusted Revenue per Share of NT$9.72 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on EBM Technologies and its competitors.
Is EBM Technologies' Cyclically Adjusted Revenue per Share too high?
EBM Technologies' current Cyclically Adjusted Revenue per Share is NT$9.72. Overall, EBM Technologies has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EBM Technologies' Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
EBM Technologies' Cyclically Adjusted Revenue per Share of NT$9.72 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on EBM Technologies and its competitors. EBM Technologies's current Cyclically Adjusted Revenue per Share is NT$9.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBM Technologies stock overvalued right now?
Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.54, compared to a current price of NT$18.15 — trading 38.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$9.72. EBM Technologies' overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current Cyclically Adjusted Revenue per Share is NT$9.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EBM Technologies (ROCO:8409) Overvalued in 2026?

Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued. The current stock price of NT$18.15 is trading 38.6% below its estimated GF Value™ of NT$29.54. GuruFocus considers EBM Technologies to be Possible Value Trap.

Key valuation signals for ROCO:8409:

  • Cyclically Adjusted Revenue per Share: NT$9.72
  • GF Value™: NT$29.54 vs. price of NT$18.15 (38.6% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EBM Technologies Business Description

Address No. 516, Sec 1, Neihu Road, 5th floor, Neihu District, Taipei, TWN
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
59GF Score

Get the complete analysis for ROCO:8409

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.15
Price
NT$29.54
GF Value